UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Which Dividend Aristocrats Etf Has Lowest Fees
Identify the Dividend Aristocrats ETF with the lowest fees and understand how fee selection affects long-term performance.
27,609 articles
This ASML No-Brainer Ahead of July 15 Earnings Report
ASML is set to report Q2 results on July 15, 2026, with investors eyeing an reaffirmed or higher FY2026 revenue targe...
Retail Moving From Crypto: Are Stocks Winning Back?
Retail traders are shifting capital from crypto to stocks, marking a sharp pivot after Bitcoin's peak. January 2026 s...
Vale Home Stocks Copper Rally Lifts BHP and VALE Surge
Copper demand is surging as data centers, EVs, and renewables push miners to expand. BHP reorganizes around copper, w...
Lilly Just Announced Fantastic News for Shareholders
Eli Lilly is delivering big news for investors. The rallying force behind recent gains comes from GLP-1 drugs, manufa...
$5,000 vs $5,000 Ethereum: Which Returns More by 2028?
Analysts compare a $5,000 XRP position against a $5,000 Ethereum bet to project which could deliver higher returns by...
Better Nuclear Energy Stock: Nano vs Oklo for Investors
Two bold players are trying to reinvent how nuclear power sits in the grid. This guide breaks down Nano Nuclear Energ...
Down 30%: Reasons Holdings That Make Nu Stock a Bargain Right Now
Nu Holdings has dropped about 30% from recent peaks. This article breaks down three grounded reasons why the decline ...
Radian Names Mike Weinbach as CEO-Elect; Thornberry Retires
Radian Group names Mike Weinbach CEO-elect as Rick Thornberry set to retire by year-end 2026. The move coincides with...
Forget Roku: This Stock Is a Better Long-Term Bet
As market focus pivots from rapid streaming growth to durable cash flow, a legacy media name offers superior long-ter...
Reasons Lilly Remains a Buy: 3 Strong Drivers for Investors
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
Apple Faces No-Win Pricing: Should Investors Be Worried?
Pricing power has long been Apple’s ace. Now the company faces a no-win pricing trap: raise prices risking demand, or...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status